Stay Updated with the Latest Credit Suisse FI Large Cap Growth Enhanced ETN FLGE News in Real Time
Find FLGE news now at Meyka AI. Stay informed with the latest Credit Suisse FI Large Cap Growth Enhanced ETN stocks updates, including price news, market analysis, and expert insights.
AAPL Stock Rises 2.19% to $316.83 as Apple App Store Revenue Falls 18%
AAPL stock rose 2.19% to $316.83 on August 19, 2026, even as new data showed that Apple’s U.S. App Store commission revenue had fallen 18% since the start of the year. The move has caught investors’ attention because Apple continues to post strong results while facing pressure on its App Store business model. Services remain…
Gaja Alternative IPO GMP Today: How Gaja Capital Is Challenging the AIF Model
Gaja Alternative IPO’s Grey Market Premium stood at ₹21 as of Thursday, August 20, 2026, 9:45 AM IST. That implies a listing price near ₹181, a 13% premium over the ₹160 upper band. The ₹550 crore issue from Gaja Capital’s asset management arm closes for subscription on August 21. Overall subscription remained modest at 0.30…
Keio University Student Arrested for ¥1M Credit Card Fraud at Sports Facility
Keio University student arrested for ¥1M credit card fraud at Tokyo sports facility. Suspect allegedly used master key to access lockers and made small purchases to avoid PIN verification.
Social Security COLA 2027: New 3.6% Estimate Shows a Smaller Raise for Retirees
The Social Security COLA for 2027 now stands at an estimated 3.6%, according to The Senior Citizens League. That’s down from 3.8% forecasts published in June and July. The drop follows July’s Consumer Price Index report, which showed inflation cooling to 3.4% year-over-year. Retirees would still see the largest benefit bump in four years if…
Moderna Soars 177% After Melanoma Vaccine Clears Phase 3 Trial on August 20
Moderna stock jumped 177% after its melanoma vaccine met Phase 3 trial endpoints. The personalized mRNA therapy showed significant improvements over standard treatment in over 1,100 patients.
Moderna Soars 177% on Melanoma Vaccine Win; August 20 Update
Moderna jumped 177% to $174.38 after Phase 3 melanoma vaccine trial success with Merck. The mRNA therapy reduced recurrence risk and represents the first approved late-stage cancer vaccine.
NEAR Protocol USD Jumps 9.1% to $1.73 on Mid-Cap Rally
NEARUSD surged 9.1% to $1.7328 in 24 hours on August 20, 2026, outpacing mid-cap peers amid mixed technical signals.
Moderna Soars 177% After Melanoma Vaccine Clears Late-Stage Trial on August 19
Moderna jumps 177% and Merck gains 12% after their personalized mRNA cancer vaccine met key goals in a Phase 3 melanoma trial, the first positive late-stage result for an mRNA cancer therapy.
Bitcoin Hits $70K as Treasury Buyback Sparks $1.23B Short Squeeze on August 19
Bitcoin jumped 5.8% to $69,500 on August 19 as the U.S. Treasury doubled bond buybacks and Trump met with crypto executives at the White House to push the CLARITY Act.